Pfizer Stock Down After Announcing Mylan Deal

Pfizer Stock Down After Announcing Mylan Deal

Todd Peters, senior vice president at Adviser Investments, has the market analysis for Monday, July 29. U.S. indexes closed with mixed results: The Dow Jones Industrial Average rose 0.1% while the S&P 500 and NASDAQ Composite fell 0.1% and 0.4%, The Federal Reserve is set to cut rates for first time since 2008 in hopes of preventing a potential downturn in the economy. In the market, Pfizer’s stock announced merging its Upjohn business with Mylan. The stock was down 3% though, due to shortcomings in revenue estimates.

Recent Videos

View All Videos

Adam Johnson on Fox Business: Why I Like to Go Against the Crowd

Adam Johnson on Fox Business: Bear-Bull Ratio May Signal a Bottom

Lowell on Fox Business: Using Cash for Defense and Offense

Lowell on Fox Business: Interest-Rate Hikes and the American Consumer

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.